TABLE 1

Potency and selectivity in vitro and in vivo



Human Recombinant Enzymes

Human Whole Blood

Rat Air Pouch

COX-1
COX-2
COX-1
COX-2
COX-1a
COX-2b
μM (±S.D.) mg/kg
COX-2 selective
Valdecoxib 150 (32) 0.005 (0.002) 21.9 (3.5) 0.2 (0.05) >200 0.06
Celecoxib 15 (3.4) 0.04 (0.013) 8.3 (1.4) 0.3 (0.06) >200 0.2
Rofecoxib >1000 0.5 (0.5) 7.0 (3.33) 0.2 (0.06) >200 1.1
Etoricoxib >1000 5 (4.3) 11.7 (4.7) 0.5 (0.08) 50 1.5
NSAIDs
Indomethacin 0.1 1.0 0.3 0.1 0.1 0.2
Naproxen 32 235 9.2 >100 0.1 1.3
Ibuprofen 38 117 3.6 10.4 0.2 2.5
Diclofenac 0.03 0.01 0.2 0.02 0.3 0.8
Etodolac >100 54 14 0.3 0.2 5.1
Nabumetone 82 >1000 >50 >50 14 22
Piroxicam 680 660 3.7 3.5 0.1 0.9
Meloxicam 1300 1700 9.5 0.3 0.7 1.0
SC-560
0.005
40
0.01
0.4
0.3
12.9
  • a Inhibition of gastric PGs.

  • b Inhibition of air pouch PGs.